FR940505-2-00131 FR940505-2-00093 [License No. 03/03-0195] CIP Capital, L.P. Notice is hereby given that CIP Capital, L.P. (CIP), 20 Valley Stream Parkway, suite 265, Malvern, PA 19355, a Federal licensee under the Small Business Investment Act of 1958, as amended (the Act), in connection with the proposed financing of a small concern is seeking an exemption under section 312 of the Act and ยง107.903 Conflicts of interest of the SBA Rules and Regulations (the Regulations) governing Small Business Investment Companies (13 CFR 107.903 (1993)). An exemption may not be granted by SBA until Notices of this transaction have been published. CIP proposes to provide equity financing to Bio-Pharm Clinical Services, Inc. (Bio-Pharm), 512 Township Line Road, Blue Bell, Pennsylvania, 19422. The financing is one of the conditions precedent to the consummation of the planned merger of Bio-Pharm into Affinity Biotech, Inc. (Affinity), 34 Mt. Pleasant Drive, Aston, PA 19041. When the merger becomes effective Affinity's name will be changed to IBAH, Inc. The financing is brought within the purview of ยง107.903(b)(1) of the Regulations because Mr. Winston J. Churchill, a General Partner of CIP, is a director of Affinity and owns more than 10% of the total shares of Affinity. The proposed financing will provide expansion capital for IBAH. Notice is further given that any person may, not later than 15 days from the date of the publication of the Notice, submit written comments on the transaction to the Associate Administrator for Investment, U.S. Small Business Administration, 409 Third Street, SW., Washington, DC 20416. A copy of this Notice shall be published, in accordance with ยง107.903(e) of the Regulations, in a newspaper of general circulation in Philadelphia, PA. (Catalog of Federal Domestic Assistance Program No. 59.011, Small Business Investment Companies) Dated: April 21, 1994. Robert D. Stillman, Associate Administrator for Investment. [FR Doc. 94&hyph;10845 Filed 5&hyph;4&hyph;94; 8:45 am] BILLING CODE 8025&hyph;01&hyph;M
